UP: Five Children Including A 2-Year-Old  Girl Gets Covaxin Trial Jab In KanpurBharat Biotech’s COVAXIN, India’s first indigenous vaccine against coronavirus. (Swarajya Magazine)

In a major development, a two-year-and-8-month-old girl has been administered the Covid vaccine in Kanpur Dehat during the ongoing trial of Bharat Biotech's Covaxin on children. The girl is the daughter of a doctor in Kanpur Dehat.

The spokesperson of the Prakhar hospital, where the girl was vaccinated, said on Thursday that around five children, including three girls and two boys, in the age group of 2-6 years were given the vaccine at the hospital in Kanpur.

The children were kept under observation for two hours before they were allowed to go home, said the spokesperson.

A safety profile of the children, who have been vaccinated, will be prepared.

In May, the Drugs Controller General of India (DCGI) had granted permission to Bharat Biotech to commence phase 2-3 trials of Covaxin on children as young as two.

Several hospitals, including AIIMS Delhi and Patna, have also commenced the Covaxin trial on kids.

This news has been published via a Syndicated feed. Only the headline is changed.

An Appeal...

Dear Reader,

As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.

Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.

We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.

Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.

Become A Patron
Become A Subscriber
Advertisement